COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1933: Articles 19321-19330  | Next

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
Xie, X., Zou, J., Fontes-Garfias, C. R., Xia, H., Swanson, K. A., Cutler, M., Cooper, D., Menachery, V. D., Weaver, S. D., Dormitzer, P. R., Shi, P.-Y.
10.1101/2021.01.07.425740 — Posted: 2021-01-07 Discussion: Onsite | Offsite
Immunoinformatic based analytics on T-cell epitope from spike protein of SARS-CoV-2 concerning Indian population.
Devi, S. S., Dwivedi, M.
10.1101/2021.01.07.425724 — Posted: 2021-01-07
Stable Interaction Of The UK B.1.1.7 lineage SARS-CoV-2 S1 Spike N501Y Mutant With ACE2 Revealed By Molecular Dynamics Simulation
Ahmed, W., Phillip, A. M., Biswas, K. H.
10.1101/2021.01.07.425307 — Posted: 2021-01-07
Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein Domains S1 and S2
Li, Z., Buck, M.
10.1101/2021.01.06.425627 — Posted: 2021-01-07
Comprehensive comparison of transcriptomes in SARS-CoV-2 infection: alternative entry routes and innate immune responses
Cao, Y., Hoffmann, D., Hao, P., Xu, X., Song, L., Kitanovski, S., Wang, J.
10.1101/2021.01.07.425716 — Posted: 2021-01-07
Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cells
Zhang, L., Ghosh, S. K., Basavarajappa, S. C., Muller-Greven, J., Penfield, J., Brewer, A., Ramakrishnan, P., Buck, M., Weinberg, A.
10.1101/2021.01.07.425621 — Posted: 2021-01-07
Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation
Maison, D. P., Ching, L. L., Shikuma, C. M., Nerurkar, V. R.
10.1101/2021.01.06.425497 — Posted: 2021-01-07 Discussion: Onsite
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
Lien, C.-E., Lin, Y.-J., Kuo, T.-Y., Campbell, J. D., Traquina, P., Lin, M.-Y., Liu, L. T. C., Chuang, Y.-S., Ku, H.-Y., Liao, C.-C., Chen, Y.-H., Jan, J.-T., Sun, C.-P., Lin, Y.-S., Wu, P.-Y., Wang, Y.-C., Tao, M.-H., Lin, Y.-L.
10.1101/2021.01.07.425674 — Posted: 2021-01-07
New targets for drug design: Importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2
Saramago, M., Barria, C., Costa, V., Souza, C. S., Viegas, S. C., Domingues, S., Lousa, D., Soares, C. M., Arraiano, C. M., Matos, R. G.
10.1101/2021.01.07.425745 — Posted: 2021-01-07
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in hamsters
Brustolin, M., Rodon, J., Rodriguez de la Concepcion, M. L., Avila-Nieto, C., Cantero, G., Perez, M., Nigeer, T., Noguera-Julian, M., Guallar, V., Valencia, A., Roca, N., Izquierdo-Useros, N., Blanco, J., Clotet, B., Bensaid, A., Carrillo, J., Vergara-Alert, J., Segales, J.
10.1101/2021.01.07.425729 — Posted: 2021-01-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).